Home
MPN Specialists
MPN Dictionary
MPN Search
Resources
Blog
Patient Stories
Podcast
01: Polycythemia Vera Diagnosis, PV Reporter, Day 1, Doomsday or Living with a Plan
02: MPN Chronicles – Interview with Dr. Pemmaraju
03: Learn Benefits of Becoming your own MPN Advocate
04: First Hematologist appointment for PV patient
05: Tips to Living Well with an MPN
News Feed
Treatment
Jakafi
INREBIC
Interferon treatment for MPNs
Int’l MPN Orgs
ASH Interviews
Dr. Jean Jacques Kiladjian ASH 2018 RuxoPeg Phase 1/2 Trial of the Combo of Ruxolitinib and Pegasys in Myelofibrosis Patients
Dr. Michael Grunwald ASH 2018 Risk Assessment and Treatment Myelofibrosis Patients at Community Oncology Practices in the U.S.
Dr. J.J. Kiladjian ASH 2018 Headline Research Studies
ASH 2017 Interview with Dr. Michael Grunwald
ASH 2017 Interview with Dr. Raajit Rampal, part 1
ASH 2017 with Dr. Raajit Rampal, part 2
ASH 2017 Interview with Dr. Jean Jacques Kiladjian, part 1
ASH 2017 Interview with Dr. Jean Jacques Kiladjian, part 2
ASH 2016 Interviews
ASH 2016 Interview with Dr Kiladjian
ASH 2016 Interview with Dr Rampal
ASH 2015 Interviews
ASH 2015 Interview with Dr John Mascarenhas
ASH 2015 Interview with Dr Angela Fleischman
ASH 2014 Interviews
ASH 2014 Interview with Dr Heinz Gisslinger
ASH 2014 interview with Dr Richard Stone
Partners
Industry Partners
Discussion Group
MPN-CC
Contact
December 15, 2019
You are here:
Home
/
Industry Partners
Industry Partners
PV Reporter recognizes and greatly appreciates the support of our Industry Partners:
error:
Content is protected !
Home
MPN Specialists
▼
MPN Dictionary
MPN Search
Resources
Blog
▼
Patient Stories
Podcast
▼
01: Polycythemia Vera Diagnosis, PV Reporter, Day 1, Doomsday or Living with a Plan
02: MPN Chronicles – Interview with Dr. Pemmaraju
03: Learn Benefits of Becoming your own MPN Advocate
04: First Hematologist appointment for PV patient
05: Tips to Living Well with an MPN
News Feed
Treatment
▼
Jakafi
INREBIC
Interferon treatment for MPNs
Int’l MPN Orgs
ASH Interviews
▼
Dr. Jean Jacques Kiladjian ASH 2018 RuxoPeg Phase 1/2 Trial of the Combo of Ruxolitinib and Pegasys in Myelofibrosis Patients
Dr. Michael Grunwald ASH 2018 Risk Assessment and Treatment Myelofibrosis Patients at Community Oncology Practices in the U.S.
Dr. J.J. Kiladjian ASH 2018 Headline Research Studies
ASH 2017 Interview with Dr. Michael Grunwald
▼
ASH 2017 Interview with Dr. Raajit Rampal, part 1
ASH 2017 with Dr. Raajit Rampal, part 2
ASH 2017 Interview with Dr. Jean Jacques Kiladjian, part 1
ASH 2017 Interview with Dr. Jean Jacques Kiladjian, part 2
ASH 2016 Interviews
▼
ASH 2016 Interview with Dr Kiladjian
ASH 2016 Interview with Dr Rampal
ASH 2015 Interviews
▼
ASH 2015 Interview with Dr John Mascarenhas
ASH 2015 Interview with Dr Angela Fleischman
ASH 2014 Interviews
▼
ASH 2014 Interview with Dr Heinz Gisslinger
ASH 2014 interview with Dr Richard Stone
Partners
▼
Industry Partners
Discussion Group
MPN-CC
Contact